CME To Stay Focused On OTC

Craig Donohue, ceo of CME Group, said his firm will continue to focus on “doing what we do well,” namely in futures and over-the-counter derivatives, reports Bloomberg.

Craig Donohue, ceo of CME Group, said his firm will continue to focus on “doing what we do well,” namely in futures and over-the-counter derivatives. Donohue made his comments in an interview, without commenting whether CME would make a bid for either Deutsche Boerse or NYSE Euronext, which recently announced a merger deal.

Click here to read the story from Bloomberg